Discussing their research on the opioid crisis during the COVID-19 pandemic, authors Rachel French, BSN, RN, Jamie Favaro, MSW, and PISC Trainee Shoshana Aronowitz, PhD, wrote in a Penn LDI article about their recent results concerning a Philadelphia program that mails Naloxone to individuals free of charge. Their work found that there were many barriers to in-person Naloxone access, such as COVID stay-at-home orders, and that free naloxone mailing programs expanded access by eliminating these barriers. They also found that despite the fact that 40% of Philadelphians are Black, only 13.6% of naloxone-by-mail requestors were Black. "We know that mail-based harm reduction efforts save lives, prevent injection-related disease transmission, and improve the lives of people who use drugs," the authors state. "Emphasizing harm reduction and racial justice is a step in the right direction."